TELO · Telomir Pharmaceuticals, Inc.
$1.14
-0.05 (-4.20%)
At close · Aug 28
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the issuance date of this Report.”View the 10-Q filed Aug 13, 2026
Market Cap
$78.40M
Shares
68.77M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$10.41M
+37%
FY2025
Diluted EPS
-$0.33
+41.1%
FY2025
Operating Cash Flow
-$3.69M
+27.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| $2.97M | $2.44M | $2.24M | $1.57M | $833.21K | |
| $3.12M | $8.1M | $9.64M | $600.19K | $20.94K | |
| $6.09M | $10.54M | $12.24M | $3.94M | $854.15K | |
| — | — | $4.34M | $1.64M | — | |
| $214.1K | $125.64K | $48K | — | — | |
| -$5.88M | -$10.41M | -$16.53M | -$13.07M | -$854.15K | |
| USD/shares | -$0.91 | -$0.33 | -$0.56 | $0.48 | -$0.03 |
| USD/shares | -$0.91 | -$0.33 | -$0.56 | $0.48 | -$0.03 |
| shares | — | 31.65M | 29.54M | 27.3M | 26.83M |
| shares | — | 31.65M | 29.54M | 27.3M | 26.83M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 4.91×
EV/EBIT
—
Peer median 12.40×
P/E (TTM)
—
Peer median 10.58×
Peer medians compare against the 297 similar-size Biotechnology companies (of 524 listed).